Media headlines about Healthequity (NASDAQ:HQY) have trended somewhat positive recently, according to Accern Sentiment. The research group scores the sentiment of news coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Healthequity earned a news impact score of 0.24 on Accern’s scale. Accern also assigned press coverage about the company an impact score of 46.1185596512092 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near future.
Several equities analysts recently issued reports on the company. Zacks Investment Research upgraded Healthequity from a “hold” rating to a “buy” rating and set a $60.00 price target on the stock in a research report on Wednesday, November 8th. BidaskClub upgraded Healthequity from a “sell” rating to a “hold” rating in a research report on Tuesday, November 7th. Chardan Capital raised their price target on Healthequity from $58.00 to $62.00 and gave the stock a “buy” rating in a research report on Wednesday, December 6th. Cantor Fitzgerald restated a “buy” rating and set a $56.00 price target on shares of Healthequity in a research report on Monday, September 25th. Finally, Citigroup assumed coverage on Healthequity in a research report on Thursday, January 4th. They set a “buy” rating on the stock. Three research analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. Healthequity currently has a consensus rating of “Buy” and an average price target of $58.33.
Shares of Healthequity (HQY) opened at $48.21 on Friday. The firm has a market capitalization of $2,936.55, a P/E ratio of 65.15, a PEG ratio of 2.00 and a beta of 1.74. Healthequity has a 1 year low of $37.62 and a 1 year high of $55.31.
Healthequity (NASDAQ:HQY) last issued its quarterly earnings data on Tuesday, December 5th. The company reported $0.17 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.13 by $0.04. The firm had revenue of $56.80 million for the quarter, compared to analyst estimates of $55.27 million. Healthequity had a return on equity of 14.47% and a net margin of 21.08%. The business’s quarterly revenue was up 31.0% compared to the same quarter last year. During the same period last year, the company earned $0.10 EPS. equities analysts expect that Healthequity will post 0.71 EPS for the current year.
In other news, Director Frank Medici sold 700 shares of Healthequity stock in a transaction that occurred on Wednesday, November 15th. The stock was sold at an average price of $51.05, for a total value of $35,735.00. Following the sale, the director now directly owns 6,381 shares in the company, valued at approximately $325,750.05. The sale was disclosed in a filing with the SEC, which is available through this link. Also, major shareholder Berkley Capital, Llc sold 373,500 shares of Healthequity stock in a transaction that occurred on Monday, November 6th. The stock was sold at an average price of $53.21, for a total value of $19,873,935.00. The disclosure for this sale can be found here. Over the last quarter, insiders sold 1,106,934 shares of company stock worth $57,943,828. Corporate insiders own 29.00% of the company’s stock.
ILLEGAL ACTIVITY WARNING: This article was first posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this article on another domain, it was stolen and reposted in violation of US and international copyright & trademark law. The legal version of this article can be read at https://www.dispatchtribunal.com/2018/01/21/somewhat-positive-news-coverage-somewhat-unlikely-to-impact-healthequity-hqy-stock-price.html.
Healthequity Company Profile
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.